Pneumocystis Pneumonia clinical trials

Explore recruiting pneumocystis pneumonia clinical trials.

Recruiting pneumocystis pneumonia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pneumocystis Pneumonia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CASPONEB - Phase II safety lead-in randomized blind placebo controlled clinical trial : efficacy and safety of caspofungin aerosols for the curative treatment of Pneumocystis pneumonia in adjunction of conventional systemic antifungal therapy

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Pneumocystis Pneumonia trials by city

Pneumocystis Pneumonia in Toronto Pneumocystis Pneumonia in Vancouver Pneumocystis Pneumonia in Montreal Pneumocystis Pneumonia in Calgary Pneumocystis Pneumonia in Edmonton Pneumocystis Pneumonia in Ottawa Pneumocystis Pneumonia in Winnipeg Pneumocystis Pneumonia in Quebec City Pneumocystis Pneumonia in Hamilton Pneumocystis Pneumonia in Kitchener Pneumocystis Pneumonia in London Pneumocystis Pneumonia in Halifax Pneumocystis Pneumonia in New York Pneumocystis Pneumonia in Los Angeles Pneumocystis Pneumonia in Chicago Pneumocystis Pneumonia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease